AAAAAA

   
Results: 1-8 |
Results: 8
Phenoxypyrimidine inhibitors of p38 alpha kinase: Synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-2-phenoxypyrimidin-4-yl) imidazoles
Authors: Boehm, JC Bower, MJ Gallagher, TF Kassis, S Johnson, SR Adams, JL
Citation: Jc. Boehm et al., Phenoxypyrimidine inhibitors of p38 alpha kinase: Synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-2-phenoxypyrimidin-4-yl) imidazoles, BIOORG MED, 11(9), 2001, pp. 1123-1126
Pyrimidinylimidazole inhibitors of p38: Cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity
Authors: Adams, JL Boehm, JC Gallagher, TF Kassis, S Webb, EF Hall, R Sorenson, M Garigipati, R Griswold, DE Lee, JC
Citation: Jl. Adams et al., Pyrimidinylimidazole inhibitors of p38: Cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity, BIOORG MED, 11(21), 2001, pp. 2867-2870
Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia
Authors: Barone, FC Irving, EA Ray, AM Lee, JC Kassis, S Kumar, S Badger, AM Legos, JJ Erhardt, JA Ohlstein, EH Hunter, AJ Harrison, DC Philpott, K Smith, BR Adams, JL Parsons, AA
Citation: Fc. Barone et al., Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia, MED RES REV, 21(2), 2001, pp. 129-145
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia
Authors: Barone, FC Irving, EA May, AM Lee, JC Kassis, S Kumar, S Badger, AM White, RF McVey, MJ Legos, JJ Erhardt, JA Nelson, AH Ohlstein, EH Hunter, AJ Ward, K Smith, BR Adams, JL Parsons, AA
Citation: Fc. Barone et al., SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia, J PHARM EXP, 296(2), 2001, pp. 312-321
Saccharomyces cerevisiae Yak1p protein kinase autophosphorylates on tyrosine residues and phosphorylates myelin basic protein on a C-terminal serine residue
Authors: Kassis, S Melhuish, T Annan, RS Chen, SL Lee, JC Livi, GP Creasy, CL
Citation: S. Kassis et al., Saccharomyces cerevisiae Yak1p protein kinase autophosphorylates on tyrosine residues and phosphorylates myelin basic protein on a C-terminal serine residue, BIOCHEM J, 348, 2000, pp. 263-272
p38 mitogen-activated protein kinase inhibitors - Mechanisms and therapeutic potentials
Authors: Lee, JC Kassis, S Kumar, S Badger, A Adams, JL
Citation: Jc. Lee et al., p38 mitogen-activated protein kinase inhibitors - Mechanisms and therapeutic potentials, PHARM THERA, 82(2-3), 1999, pp. 389-397
Selective inhibition of phospholipases by atiprimod, a macrophage targeting antiarthritic compound
Authors: Handler, JA Badger, A Genell, CA Klinkner, AM Kassis, S Waites, CR Bugelski, PJ
Citation: Ja. Handler et al., Selective inhibition of phospholipases by atiprimod, a macrophage targeting antiarthritic compound, TOX APPL PH, 159(1), 1999, pp. 9-17
Pyrimidinylimidazole inhibitors of CSBP/P37 kinase demonstrating decreasedinhibition of hepatic cytochrome P450 enzymes
Authors: Adams, JL Boehm, JC Kassis, S Gorycki, PD Webb, EF Hall, R Sorenson, M Lee, JC Ayrton, A Griswold, DE Gallagher, TF
Citation: Jl. Adams et al., Pyrimidinylimidazole inhibitors of CSBP/P37 kinase demonstrating decreasedinhibition of hepatic cytochrome P450 enzymes, BIOORG MED, 8(22), 1998, pp. 3111-3116
Risultati: 1-8 |